Outro

Join Dr. Mark Horowitz, lead author of the Maudsley Deprescribing Guidelines and co-founder of Outro Health, in conversation with Dr. Adam Urato, a Maternal-Fetal Medicine specialist who spoke at the FDA's first panel on SSRIs and pregnancy. This interactive Q&A addresses making medication decisions safer and more transparent for pregnancy planning, conception, and women's health.

Join psychiatrist and researcher Dr. Mark Horowitz in conversation with trauma-informed peer support leader Angie Peacock for an intimate discussion about psychiatric drug withdrawal, informed consent, and building safer mental health care systems. This recorded webinar brings together two of the most respected voices in the field to explore what gets overlooked in traditional psychiatric care and how real-world experiences can inform better treatment approaches.

This comprehensive session covers topics ranging from managing withdrawal symptoms to understanding the science of receptor adaptation, offering crucial information for patients, clinicians, and advocates seeking safer approaches to antidepressant discontinuation. Dr. Horowitz's clinical expertise, combined with his personal experience of antidepressant withdrawal, provides a unique perspective on the challenges patients face when attempting to stop these medications safely.

Join us for this comprehensive Q&A session where Dr. Mark Horowitz, the world's foremost antidepressant tapering expert, answers your most pressing questions about antidepressant withdrawal, the science of safe tapering, and evidence-based approaches to psychiatric medication discontinuation.

Join Dr. Mark Horowitz for this comprehensive session on safely tapering atypical antidepressants, including Bupropion (Wellbutrin), Trazodone (Desyrel), and Mirtazapine (Remeron). While these medications fall outside the SSRI/SNRI category, they still present unique tapering challenges that require careful consideration.

More and more people are expressing a desire to stop taking antidepressants - but many therapists are unsure how to support them through the process. This essential webinar provides both scientific and therapeutic context for understanding antidepressant tapering, giving therapists the tools they need to support clients safely and ethically.

Comprehensive recorded webinar with Dr. Bryan Shapiro, Medical Director at Outro Health, on safely tapering off Paxil (paroxetine) - one of the most challenging antidepressants to discontinue.

Known for their short half-lives and dual action on serotonin and norepinephrine, these SNRIs are associated with some of the most severe and persistent withdrawal symptoms reported by patients. In this comprehensive session, Dr. Horowitz explores the science behind these symptoms and demonstrates how hyperbolic tapering can dramatically improve patient safety and outcomes.

Despite being called one of the "most tolerable" antidepressants, many people face serious withdrawal challenges when trying to stop Zoloft (sertraline).

Join Dr. Mark Horowitz, Scientific Co-Founder of Outro Health and co-author of the Maudsley Deprescribing Guidelines, for a groundbreaking discussion on Prozac (fluoxetine) tapering that challenges common misconceptions.

Watch this webinar with Dr. Bryan Shapiro, Medical Advisor at Outro Health, for a crucial discussion on safely tapering one of the most challenging antidepressants to discontinue.

Are you or someone you know considering coming off Lexapro (escitalopram) or Celexa (citalopram)? Dr. Mark Horowitz shares cutting-edge research and practical strategies for safely tapering these commonly prescribed SSRIs.

Most patients receive little to no support when discontinuing antidepressants with withdrawal symptoms often misdiagnosed as relapse. In this comprehensive webinar, Dr. Mark Horowitz reveals why standard tapering methods fail and introduces hyperbolic tapering, a revolutionary neuroscience-based approach.

Dr. Ellen Vora, MD, a holistic psychiatrist and author of "The Anatomy of Anxiety," joins Charlotte Herring from Outro Health to discuss integrative approaches to mental health and antidepressant tapering.

Join expert practitioners Charlotte Herring and Nicole Lamberson for an essential webinar on supporting loved ones through antidepressant deprescribing.

Effexor (venlafaxine) is one of the most difficult antidepressants to stop, with a short half-life and notoriously severe withdrawal symptoms.

Adele Framer's personal experience of antidepressant withdrawal and protracted withdrawal led her to begin the peer-support website Surviving Antidepressants where she has counselled over 10,000 people through their journeys off of antidepressants.

In this webinar, Dr. Mark Horowitz and Maria Pastoor discuss the science behind tapering off Cymbalta, clinical considerations, as well as insights from the leading peer support group.